Sovaldi

Gilead: This Baby Has Been Thrown Away With The Bathwater
Seeking Alpha
Wed, 04/16/14 - 10:19 am
Gilead Sciences
Sovaldi
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?
Motley Fool
Tue, 04/15/14 - 10:36 am
hepatitis C
Gilead Sciences
Sovaldi
Merck
Bristol-Myers Squibb
daclatasvir
asunaprevir
MK-5172
MK-8742
Price of New Hepatitis C Drugs Not So Daunting After All
Bloomberg
Mon, 04/14/14 - 08:35 am
drug pricing
hepatitis C
Sovaldi
Gilead Sciences
Encouraging Results on Gilead's Sovaldi
Yahoo/Zacks
Sat, 04/12/14 - 10:13 am
Gilead Sciences
Sovaldi
HCV
hepatitis
hepatitis C
Texas Medicaid holds off on proposed limits for Gilead hepatitis drug
Yahoo/Reuters
Fri, 04/11/14 - 03:38 pm
Texas
Gilead Sciences
Medicaid
hepatitis C
Sovaldi
Natco looking to block Indian patent for Gilead's Sovaldi
Fierce Pharma
Fri, 04/11/14 - 11:41 am
India
Natco
Gilead Sciences
Sovaldi
hepatitis C
Doctors welcome hepatitis C drug rivals, Gilead still leads
Yahoo/Reuters
Fri, 04/11/14 - 08:47 am
physicians
hepatitis C
Gilead Sciences
Sovaldi
Merck
AbbVie
Bristol-Myers Squibb
Gilead Sciences: How Big a Threat is Merck?
Barron's
Thu, 04/10/14 - 10:52 am
Gilead Sciences
Merck
hepatitis C
MK-5172
MK-8742
Sovaldi
Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill
Bloomberg
Thu, 04/10/14 - 07:39 am
Merck
Gilead
hepatitis C
MK-5172
MK-8742
Sovaldi
Gilead Sciences: Pricing Concerns Just Noise?
Barron's
Wed, 04/9/14 - 11:17 am
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
WHO joins clamour to make new hepatitis C pills affordable
Yahoo/Reuters
Wed, 04/9/14 - 08:54 am
WHO
hepatitis C
Sovaldi
Gilead Sciences
Express Scripts assembling anti-Sovaldi coalition to shut out Gilead hep C drug
Fierce Pharma
Tue, 04/8/14 - 11:51 am
Sovaldi
hepatitis C
Gilead Sciences
Express Scripts
drug pricing
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Mon, 04/7/14 - 12:54 pm
physicians
Sovaldi
Gilead Sciences
hepatitis C
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Mon, 04/7/14 - 10:24 am
immuno-oncology
Sovaldi
Gilead Sciences
Teva Pharmaceuticals
Copaxone
GSK
Breo Ellipta
Forest Labs
Actavis
M&A
Affordable Care Act
biosimilars
PCSK9 inhibitors
Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wed, 04/2/14 - 09:41 pm
Sovaldi
hepatitis C
Gilead Sciences
The Hunt For Hidden Value: Gilead Gilded In Gold
Seeking Alpha
Tue, 04/1/14 - 08:59 am
Gilead
Sovaldi
Congress Makes Sovaldi A Scapegoat: The Cost-Innovation Paradox In The US Healthcare System
Forbes
Thu, 03/27/14 - 10:58 am
Gilead Sciences
drug pricing
Sovaldi
US Congress
Will The Hep-C Drug, Sovaldi, Drive Gilead To The Top Of The Biopharm Industry?
Forbes
Tue, 03/25/14 - 08:05 am
hepatitis C
Gilead Sciences
Sovaldi
Sovaldi's Patent War
Seeking Alpha
Mon, 03/24/14 - 06:00 pm
Sovaldi
Gilead Sciences
hepatitis C
patents
One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug
Forbes
Mon, 03/24/14 - 08:52 am
drug pricing
Henry Waxman
Sovaldi
Gilead Sciences

Pages